We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current TYRA market cap is 848.26M. The company's latest EPS is USD -1.6056 and P/E is -12.44.
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -15.02M | -14.33M | -16.01M | -23.96M | -25.63M |
| Net Income | -12.9M | -11.88M | -13.27M | -21.15M | -22.83M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -3.12M | -9.3M | -26.29M | -58.93M | -79.95M |
| Net Income | -4.07M | -9.34M | -26.29M | -55.33M | -69.13M |
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 266.18M | 255.06M | 250.01M | 238.36M | 225.86M |
| Total Liabilities | 8.35M | 6.27M | 11.44M | 16.19M | 21.6M |
| Total Equity | 257.83M | 248.79M | 238.57M | 222.17M | 204.26M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 528k | 16.01M | 306.7M | 266.18M | 225.86M |
| Total Liabilities | 5.27M | 2M | 4.96M | 8.35M | 21.6M |
| Total Equity | -4.74M | -13.64M | 301.74M | 257.83M | 204.26M |
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -50.29M | -9.85M | -19.46M | -36.61M | -50.14M |
| Investing | -559k | -41k | -84k | -167k | -144.61M |
| Financing | 632k | 376k | 746k | 1.21M | 1.54M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -2.62M | -7.76M | -23.75M | -50.29M | -50.14M |
| Investing | -20k | -312k | -645k | -559k | -144.61M |
| Financing | 157k | 23.43M | 311.35M | 632k | 1.54M |
| Market Cap | 848.26M |
| Price to Earnings Ratio | -12.44 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 14.82 |
| Price to Book Ratio | 4.21 |
| Dividend Yield | - |
| Shares Outstanding | 43.06M |
| Average Volume (1 week) | 230.89k |
| Average Volume (1 Month) | 145.71k |
| 52 Week Change | 31.42% |
| 52 Week High | 20.67 |
| 52 Week Low | 10.38 |
| Spread (Intraday) | 0.12 (0.61%) |
| Company Name | Tyra Biosciences Inc |
| Address |
corporation trust center wilmington, delaware 19801 |
| Website | https://www.tyra.bio |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
